| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 215 | 2025 | 12253 | 8.550 |
Why?
|
| Metformin | 37 | 2023 | 909 | 4.500 |
Why?
|
| Hypoglycemic Agents | 35 | 2023 | 3110 | 3.380 |
Why?
|
| Polymorphism, Single Nucleotide | 143 | 2024 | 16053 | 3.330 |
Why?
|
| Blood Glucose | 73 | 2023 | 6435 | 2.850 |
Why?
|
| Genome-Wide Association Study | 113 | 2024 | 12801 | 2.720 |
Why?
|
| Genetic Predisposition to Disease | 103 | 2025 | 18068 | 2.430 |
Why?
|
| Pharmacogenetics | 11 | 2020 | 683 | 2.230 |
Why?
|
| Glipizide | 6 | 2023 | 48 | 2.130 |
Why?
|
| Insulin | 56 | 2023 | 6610 | 1.940 |
Why?
|
| Genetic Variation | 46 | 2024 | 6611 | 1.890 |
Why?
|
| Insulin Resistance | 42 | 2024 | 3982 | 1.890 |
Why?
|
| Fasting | 27 | 2022 | 1610 | 1.670 |
Why?
|
| Diabetic Nephropathies | 13 | 2024 | 973 | 1.590 |
Why?
|
| Diabetes Mellitus | 26 | 2024 | 5892 | 1.510 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 11 | 2018 | 153 | 1.430 |
Why?
|
| Sulfonylurea Compounds | 5 | 2021 | 220 | 1.360 |
Why?
|
| Genotype | 66 | 2023 | 13048 | 1.340 |
Why?
|
| Hyperglycemia | 8 | 2023 | 1389 | 1.240 |
Why?
|
| Proinsulin | 6 | 2023 | 135 | 1.220 |
Why?
|
| Diabetes Mellitus, Type 1 | 18 | 2024 | 3447 | 1.190 |
Why?
|
| Incretins | 4 | 2022 | 100 | 1.170 |
Why?
|
| Genetic Loci | 21 | 2022 | 2630 | 1.090 |
Why?
|
| TCF Transcription Factors | 7 | 2010 | 138 | 1.080 |
Why?
|
| Obesity | 35 | 2023 | 13091 | 0.960 |
Why?
|
| Glucose | 21 | 2023 | 4352 | 0.930 |
Why?
|
| Polymorphism, Genetic | 10 | 2012 | 4251 | 0.930 |
Why?
|
| Mendelian Randomization Analysis | 12 | 2022 | 1040 | 0.880 |
Why?
|
| Prediabetic State | 9 | 2024 | 548 | 0.840 |
Why?
|
| Amino Acid Substitution | 9 | 2018 | 1742 | 0.810 |
Why?
|
| Multifactorial Inheritance | 13 | 2024 | 1423 | 0.810 |
Why?
|
| Humans | 324 | 2025 | 768970 | 0.800 |
Why?
|
| Alleles | 37 | 2022 | 6901 | 0.760 |
Why?
|
| Haplotypes | 12 | 2021 | 2725 | 0.750 |
Why?
|
| Gene Frequency | 31 | 2024 | 3626 | 0.750 |
Why?
|
| Diabetes, Gestational | 9 | 2024 | 1263 | 0.730 |
Why?
|
| Diabetes Complications | 2 | 2020 | 1320 | 0.700 |
Why?
|
| Glucose Tolerance Test | 17 | 2023 | 1183 | 0.680 |
Why?
|
| Anti-Obesity Agents | 1 | 2023 | 240 | 0.680 |
Why?
|
| Glucokinase | 3 | 2021 | 99 | 0.660 |
Why?
|
| Pyrophosphatases | 6 | 2010 | 142 | 0.660 |
Why?
|
| Receptor, Melatonin, MT2 | 5 | 2022 | 83 | 0.660 |
Why?
|
| Phenotype | 35 | 2024 | 16731 | 0.650 |
Why?
|
| Phosphoric Diester Hydrolases | 6 | 2010 | 205 | 0.640 |
Why?
|
| Quantitative Trait Loci | 21 | 2022 | 2133 | 0.640 |
Why?
|
| Biological Specimen Banks | 3 | 2021 | 789 | 0.630 |
Why?
|
| Body Mass Index | 41 | 2024 | 13055 | 0.620 |
Why?
|
| Genetic Linkage | 7 | 2016 | 2342 | 0.620 |
Why?
|
| Genome, Human | 13 | 2021 | 4456 | 0.620 |
Why?
|
| Life Style | 23 | 2022 | 3931 | 0.600 |
Why?
|
| Linkage Disequilibrium | 13 | 2021 | 2000 | 0.600 |
Why?
|
| Genomics | 11 | 2023 | 5928 | 0.580 |
Why?
|
| Glucose Intolerance | 4 | 2023 | 579 | 0.570 |
Why?
|
| Metabolome | 8 | 2022 | 1009 | 0.570 |
Why?
|
| Insulin-Secreting Cells | 8 | 2024 | 899 | 0.560 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 3 | 2009 | 144 | 0.550 |
Why?
|
| PPAR gamma | 6 | 2016 | 487 | 0.550 |
Why?
|
| Risk Reduction Behavior | 5 | 2017 | 1119 | 0.530 |
Why?
|
| Weight Loss | 12 | 2023 | 2721 | 0.530 |
Why?
|
| Hypoglycemia | 2 | 2023 | 895 | 0.520 |
Why?
|
| Risk Factors | 63 | 2024 | 74976 | 0.510 |
Why?
|
| Female | 167 | 2024 | 397515 | 0.510 |
Why?
|
| Receptors, Drug | 2 | 2007 | 157 | 0.500 |
Why?
|
| Chemokines, CC | 1 | 2016 | 286 | 0.490 |
Why?
|
| Multigene Family | 1 | 2018 | 1082 | 0.490 |
Why?
|
| Male | 153 | 2024 | 365203 | 0.480 |
Why?
|
| Insulin Receptor Substrate Proteins | 5 | 2021 | 558 | 0.470 |
Why?
|
| Amino Acids, Aromatic | 2 | 2013 | 36 | 0.460 |
Why?
|
| Receptors, Glucagon | 2 | 2015 | 90 | 0.460 |
Why?
|
| Chromans | 4 | 2011 | 116 | 0.460 |
Why?
|
| Metabolic Diseases | 2 | 2018 | 684 | 0.450 |
Why?
|
| Monocarboxylic Acid Transporters | 4 | 2019 | 81 | 0.450 |
Why?
|
| Albuminuria | 2 | 2015 | 658 | 0.450 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 4 | 2017 | 93 | 0.450 |
Why?
|
| Kidney Failure, Chronic | 7 | 2021 | 2493 | 0.440 |
Why?
|
| Chymotrypsin | 1 | 2013 | 137 | 0.440 |
Why?
|
| Diet | 9 | 2023 | 8088 | 0.430 |
Why?
|
| Middle Aged | 108 | 2024 | 223737 | 0.420 |
Why?
|
| Chromosome Mapping | 12 | 2018 | 4625 | 0.420 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2021 | 540 | 0.420 |
Why?
|
| Adult | 101 | 2024 | 223851 | 0.420 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 896 | 0.420 |
Why?
|
| Potassium Channels | 2 | 2007 | 538 | 0.410 |
Why?
|
| Integrin alpha1 | 1 | 2012 | 13 | 0.410 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2007 | 567 | 0.400 |
Why?
|
| Tryptophan Hydroxylase | 3 | 1996 | 93 | 0.400 |
Why?
|
| Islets of Langerhans | 7 | 2024 | 1351 | 0.390 |
Why?
|
| Dietary Fats | 2 | 2019 | 2002 | 0.390 |
Why?
|
| Carcinoid Tumor | 1 | 2013 | 224 | 0.380 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2013 | 268 | 0.380 |
Why?
|
| Down Syndrome | 4 | 2017 | 919 | 0.380 |
Why?
|
| Pineal Gland | 3 | 1996 | 158 | 0.370 |
Why?
|
| Glucose Metabolism Disorders | 2 | 2013 | 52 | 0.370 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2013 | 619 | 0.370 |
Why?
|
| Case-Control Studies | 34 | 2024 | 22296 | 0.370 |
Why?
|
| Thiazolidinediones | 4 | 2011 | 461 | 0.370 |
Why?
|
| Genetic Association Studies | 13 | 2020 | 2748 | 0.360 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2013 | 180 | 0.360 |
Why?
|
| Mutation, Missense | 9 | 2019 | 2592 | 0.350 |
Why?
|
| Cardiovascular Diseases | 14 | 2024 | 15661 | 0.350 |
Why?
|
| Knowledge | 2 | 2010 | 178 | 0.340 |
Why?
|
| Cerebrospinal Fluid | 1 | 2012 | 545 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1408 | 0.330 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 282 | 0.330 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 5 | 2018 | 174 | 0.330 |
Why?
|
| Genetic Markers | 7 | 2023 | 2604 | 0.320 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 317 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2008 | 350 | 0.300 |
Why?
|
| Coronary Artery Disease | 6 | 2024 | 6569 | 0.300 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 3450 | 0.300 |
Why?
|
| Resistin | 1 | 2008 | 172 | 0.300 |
Why?
|
| Information Dissemination | 1 | 2016 | 1141 | 0.290 |
Why?
|
| Primary Prevention | 1 | 2015 | 1187 | 0.290 |
Why?
|
| Kidney Diseases | 2 | 2016 | 2100 | 0.290 |
Why?
|
| Receptor, Melanocortin, Type 4 | 3 | 2021 | 131 | 0.280 |
Why?
|
| Incidence | 21 | 2024 | 21547 | 0.280 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 1752 | 0.280 |
Why?
|
| Phosphoproteins | 2 | 2007 | 2452 | 0.280 |
Why?
|
| Genetic Counseling | 4 | 2016 | 634 | 0.270 |
Why?
|
| Cohort Studies | 27 | 2024 | 41808 | 0.270 |
Why?
|
| Cation Transport Proteins | 4 | 2014 | 326 | 0.260 |
Why?
|
| Homeostasis | 7 | 2019 | 3347 | 0.260 |
Why?
|
| Insulysin | 1 | 2006 | 49 | 0.260 |
Why?
|
| Reproduction | 2 | 2012 | 646 | 0.260 |
Why?
|
| Lysine | 3 | 2008 | 1000 | 0.250 |
Why?
|
| Adiponectin | 5 | 2012 | 1117 | 0.250 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2830 | 0.250 |
Why?
|
| DNA | 2 | 2022 | 7214 | 0.250 |
Why?
|
| Founder Effect | 2 | 2018 | 185 | 0.250 |
Why?
|
| Waist-Hip Ratio | 7 | 2022 | 520 | 0.240 |
Why?
|
| Hydrocortisone | 1 | 2013 | 1841 | 0.240 |
Why?
|
| Meta-Analysis as Topic | 11 | 2021 | 1364 | 0.240 |
Why?
|
| C-Peptide | 3 | 2023 | 443 | 0.240 |
Why?
|
| Aged | 57 | 2024 | 171786 | 0.240 |
Why?
|
| Sphenoid Sinus | 1 | 2005 | 101 | 0.240 |
Why?
|
| Placenta | 2 | 2024 | 1725 | 0.240 |
Why?
|
| Risk | 12 | 2020 | 9621 | 0.230 |
Why?
|
| Proportional Hazards Models | 9 | 2019 | 12562 | 0.230 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2005 | 101 | 0.230 |
Why?
|
| Genetics, Population | 3 | 2021 | 944 | 0.230 |
Why?
|
| Exercise | 5 | 2021 | 5954 | 0.230 |
Why?
|
| Lipids | 4 | 2021 | 3345 | 0.230 |
Why?
|
| Epigenesis, Genetic | 7 | 2025 | 3836 | 0.220 |
Why?
|
| Databases, Genetic | 5 | 2021 | 1758 | 0.220 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 3 | 2024 | 127 | 0.220 |
Why?
|
| Triglycerides | 9 | 2022 | 2464 | 0.220 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2005 | 327 | 0.220 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 126 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 458 | 0.210 |
Why?
|
| Diabetic Retinopathy | 2 | 2024 | 1299 | 0.210 |
Why?
|
| Circadian Rhythm | 5 | 2020 | 2593 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 2812 | 0.210 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 665 | 0.200 |
Why?
|
| Algorithms | 6 | 2024 | 14201 | 0.200 |
Why?
|
| Hypercalcemia | 1 | 2005 | 424 | 0.200 |
Why?
|
| Rhabdomyosarcoma | 1 | 2005 | 358 | 0.200 |
Why?
|
| Waist Circumference | 5 | 2022 | 935 | 0.200 |
Why?
|
| Melatonin | 4 | 2022 | 670 | 0.190 |
Why?
|
| Environment | 4 | 2016 | 1122 | 0.190 |
Why?
|
| Energy Intake | 3 | 2018 | 2146 | 0.190 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2005 | 383 | 0.190 |
Why?
|
| Isoenzymes | 1 | 2006 | 1687 | 0.190 |
Why?
|
| Proteins | 7 | 2019 | 6011 | 0.180 |
Why?
|
| Dyslipidemias | 3 | 2021 | 873 | 0.180 |
Why?
|
| Mannosidases | 1 | 2020 | 21 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2013 | 313 | 0.180 |
Why?
|
| Disease Progression | 8 | 2024 | 13674 | 0.180 |
Why?
|
| Vitamin D Deficiency | 3 | 2018 | 1388 | 0.180 |
Why?
|
| Mexico | 5 | 2018 | 769 | 0.180 |
Why?
|
| Membrane Proteins | 5 | 2018 | 7885 | 0.180 |
Why?
|
| Genes, Recessive | 2 | 2022 | 625 | 0.180 |
Why?
|
| Socioeconomic Factors | 5 | 2023 | 7861 | 0.180 |
Why?
|
| Prenatal Diagnosis | 1 | 2007 | 1275 | 0.170 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1056 | 0.170 |
Why?
|
| Mexican Americans | 2 | 2017 | 165 | 0.170 |
Why?
|
| Fractures, Bone | 1 | 2012 | 2063 | 0.170 |
Why?
|
| Glomerular Basement Membrane | 1 | 2019 | 35 | 0.170 |
Why?
|
| Cluster Analysis | 4 | 2022 | 2732 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 859 | 0.170 |
Why?
|
| Bone Density | 2 | 2012 | 3574 | 0.170 |
Why?
|
| Prospective Studies | 15 | 2024 | 54962 | 0.170 |
Why?
|
| Finland | 3 | 2017 | 609 | 0.170 |
Why?
|
| Genetic Heterogeneity | 4 | 2016 | 737 | 0.170 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2019 | 42 | 0.160 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 11932 | 0.160 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2020 | 1672 | 0.160 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2022 | 374 | 0.160 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 8760 | 0.160 |
Why?
|
| Collagen Type IV | 1 | 2019 | 125 | 0.160 |
Why?
|
| Amyloid beta-Peptides | 1 | 2012 | 3913 | 0.160 |
Why?
|
| 2-Aminoadipic Acid | 2 | 2022 | 32 | 0.160 |
Why?
|
| Skin Diseases | 1 | 2007 | 1085 | 0.160 |
Why?
|
| Odds Ratio | 6 | 2019 | 9684 | 0.160 |
Why?
|
| Carbohydrate Metabolism | 1 | 2020 | 262 | 0.160 |
Why?
|
| Endocrinology | 2 | 2020 | 443 | 0.150 |
Why?
|
| Adiposity | 5 | 2022 | 1895 | 0.150 |
Why?
|
| Europe | 7 | 2022 | 3441 | 0.150 |
Why?
|
| Longitudinal Studies | 9 | 2024 | 14794 | 0.150 |
Why?
|
| Glucose-6-Phosphatase | 2 | 2015 | 71 | 0.150 |
Why?
|
| Open Reading Frames | 1 | 2021 | 818 | 0.150 |
Why?
|
| Cytosine | 1 | 2019 | 213 | 0.150 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2018 | 41 | 0.150 |
Why?
|
| Hyperuricemia | 1 | 2021 | 223 | 0.150 |
Why?
|
| Biotransformation | 1 | 2018 | 166 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 507 | 0.150 |
Why?
|
| Decision Making | 2 | 2012 | 3953 | 0.150 |
Why?
|
| Electronic Health Records | 3 | 2024 | 4879 | 0.150 |
Why?
|
| Massachusetts | 6 | 2013 | 8894 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2013 | 2911 | 0.140 |
Why?
|
| Cross-Sectional Studies | 11 | 2023 | 26395 | 0.140 |
Why?
|
| Atherosclerosis | 3 | 2022 | 3431 | 0.140 |
Why?
|
| Glycerol | 1 | 2018 | 274 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2023 | 3811 | 0.140 |
Why?
|
| Body Height | 2 | 2017 | 1569 | 0.140 |
Why?
|
| Bayes Theorem | 3 | 2022 | 2360 | 0.140 |
Why?
|
| Exercise Therapy | 4 | 2019 | 939 | 0.140 |
Why?
|
| Sodium | 1 | 2022 | 1597 | 0.140 |
Why?
|
| Overweight | 4 | 2016 | 2448 | 0.140 |
Why?
|
| Treatment Failure | 1 | 2023 | 2664 | 0.140 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 9618 | 0.140 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2016 | 61 | 0.140 |
Why?
|
| Genomic Library | 1 | 1996 | 189 | 0.130 |
Why?
|
| Causality | 3 | 2021 | 1256 | 0.130 |
Why?
|
| Vitamin D | 3 | 2018 | 3311 | 0.130 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 1326 | 0.130 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 213 | 0.130 |
Why?
|
| Diabetic Neuropathies | 1 | 2020 | 410 | 0.130 |
Why?
|
| Metabolomics | 2 | 2018 | 1675 | 0.130 |
Why?
|
| Adipocytes | 2 | 2024 | 1199 | 0.130 |
Why?
|
| Metalloendopeptidases | 1 | 2018 | 386 | 0.130 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2017 | 271 | 0.130 |
Why?
|
| Transcription Factors | 7 | 2023 | 12174 | 0.130 |
Why?
|
| Betaine | 1 | 2016 | 90 | 0.130 |
Why?
|
| Chromosomes, Human, X | 1 | 2018 | 321 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2006 | 2986 | 0.130 |
Why?
|
| Glucagon | 1 | 2018 | 535 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 542 | 0.130 |
Why?
|
| United States | 22 | 2024 | 73186 | 0.130 |
Why?
|
| Disease | 1 | 2021 | 673 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 4 | 2021 | 4785 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2014 | 411 | 0.130 |
Why?
|
| Diet, Reducing | 2 | 2016 | 487 | 0.120 |
Why?
|
| Lipodystrophy | 1 | 2016 | 145 | 0.120 |
Why?
|
| Mutation | 4 | 2022 | 30266 | 0.120 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2015 | 83 | 0.120 |
Why?
|
| Adolescent | 16 | 2024 | 89244 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2017 | 605 | 0.120 |
Why?
|
| Lipid Metabolism | 4 | 2021 | 1904 | 0.120 |
Why?
|
| Autoantigens | 1 | 2019 | 891 | 0.120 |
Why?
|
| Cryptochromes | 1 | 2015 | 49 | 0.120 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 20245 | 0.120 |
Why?
|
| Pregnancy | 12 | 2024 | 30265 | 0.120 |
Why?
|
| Aging | 3 | 2021 | 8745 | 0.120 |
Why?
|
| NAD | 1 | 2019 | 618 | 0.120 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2015 | 86 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2019 | 570 | 0.120 |
Why?
|
| Glycolysis | 1 | 2019 | 838 | 0.120 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 33 | 0.120 |
Why?
|
| Enteroendocrine Cells | 2 | 2024 | 79 | 0.120 |
Why?
|
| Regression Analysis | 3 | 2014 | 6346 | 0.120 |
Why?
|
| Homeodomain Proteins | 7 | 2023 | 2431 | 0.120 |
Why?
|
| Consensus | 2 | 2023 | 3214 | 0.110 |
Why?
|
| Area Under Curve | 2 | 2018 | 1645 | 0.110 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2016 | 251 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1794 | 0.110 |
Why?
|
| Evidence-Based Medicine | 4 | 2023 | 3709 | 0.110 |
Why?
|
| Fetus | 1 | 2021 | 1882 | 0.110 |
Why?
|
| Motor Activity | 3 | 2015 | 2713 | 0.110 |
Why?
|
| Gout | 1 | 2021 | 621 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2013 | 18 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1143 | 0.110 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2014 | 103 | 0.110 |
Why?
|
| Fats | 1 | 2014 | 99 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1088 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2012 | 800 | 0.110 |
Why?
|
| Thyroid Diseases | 1 | 2017 | 385 | 0.110 |
Why?
|
| Norepinephrine | 1 | 1996 | 899 | 0.110 |
Why?
|
| Treatment Outcome | 9 | 2023 | 65480 | 0.110 |
Why?
|
| Siblings | 3 | 2006 | 828 | 0.110 |
Why?
|
| DNA Methylation | 3 | 2023 | 4432 | 0.110 |
Why?
|
| Risk Assessment | 10 | 2021 | 24333 | 0.110 |
Why?
|
| Heart Diseases | 2 | 2018 | 2819 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 45 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3810 | 0.110 |
Why?
|
| Mitochondria | 2 | 2019 | 3682 | 0.110 |
Why?
|
| Plasma | 1 | 2016 | 585 | 0.100 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 173 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 1486 | 0.100 |
Why?
|
| Animals | 21 | 2020 | 169335 | 0.100 |
Why?
|
| Nephrology | 1 | 2016 | 270 | 0.100 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2015 | 554 | 0.100 |
Why?
|
| Receptors, Adiponectin | 1 | 2012 | 82 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2019 | 1295 | 0.100 |
Why?
|
| Eating | 4 | 2023 | 1542 | 0.100 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 268 | 0.100 |
Why?
|
| Carbolines | 1 | 2014 | 295 | 0.100 |
Why?
|
| Behavior | 1 | 1995 | 543 | 0.100 |
Why?
|
| Health Behavior | 3 | 2016 | 2649 | 0.100 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1469 | 0.100 |
Why?
|
| Nuclear Proteins | 4 | 2021 | 5804 | 0.100 |
Why?
|
| Drug Resistance | 1 | 2018 | 1599 | 0.100 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2022 | 26 | 0.100 |
Why?
|
| Prevalence | 6 | 2024 | 15879 | 0.100 |
Why?
|
| KCNQ1 Potassium Channel | 3 | 2021 | 104 | 0.100 |
Why?
|
| Birth Weight | 2 | 2020 | 2121 | 0.100 |
Why?
|
| Hypothyroidism | 1 | 2017 | 667 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1169 | 0.100 |
Why?
|
| Predictive Value of Tests | 7 | 2023 | 15471 | 0.100 |
Why?
|
| Heterozygote | 5 | 2018 | 2798 | 0.100 |
Why?
|
| Genetic Testing | 5 | 2012 | 3591 | 0.100 |
Why?
|
| Anorexia Nervosa | 1 | 2021 | 1364 | 0.090 |
Why?
|
| RNA, Messenger | 5 | 2023 | 12806 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 3 | 2021 | 527 | 0.090 |
Why?
|
| Sweden | 2 | 2021 | 1382 | 0.090 |
Why?
|
| Spectrum Analysis | 1 | 2013 | 449 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2018 | 3449 | 0.090 |
Why?
|
| Seasons | 2 | 2015 | 1524 | 0.090 |
Why?
|
| Liver | 6 | 2021 | 7578 | 0.090 |
Why?
|
| Pedigree | 4 | 2017 | 4545 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 878 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2011 | 2820 | 0.090 |
Why?
|
| Population Groups | 1 | 2012 | 208 | 0.090 |
Why?
|
| Phosphate Transport Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Receptors, Peptide | 1 | 2012 | 280 | 0.090 |
Why?
|
| Cholesterol, LDL | 4 | 2022 | 2403 | 0.090 |
Why?
|
| Placebos | 2 | 2012 | 1667 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 572 | 0.090 |
Why?
|
| Weight Gain | 3 | 2023 | 2359 | 0.090 |
Why?
|
| Androgens | 2 | 2015 | 1285 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 137 | 0.090 |
Why?
|
| Natriuretic Peptides | 1 | 2011 | 156 | 0.090 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 367 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 1737 | 0.090 |
Why?
|
| Body Composition | 3 | 2019 | 2462 | 0.090 |
Why?
|
| Pancreas | 2 | 2014 | 1700 | 0.090 |
Why?
|
| Poland | 2 | 2007 | 197 | 0.090 |
Why?
|
| Computational Biology | 5 | 2023 | 3562 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2010 | 171 | 0.080 |
Why?
|
| Motivation | 4 | 2012 | 2025 | 0.080 |
Why?
|
| Endonucleases | 1 | 2012 | 371 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 980 | 0.080 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 9549 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 2297 | 0.080 |
Why?
|
| Adipose Tissue | 4 | 2017 | 3335 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2017 | 1068 | 0.080 |
Why?
|
| Receptors, Cannabinoid | 1 | 2009 | 43 | 0.080 |
Why?
|
| Canada | 2 | 2022 | 2130 | 0.080 |
Why?
|
| Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
| Iceland | 1 | 2009 | 183 | 0.080 |
Why?
|
| Receptor, Insulin | 2 | 2013 | 838 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 874 | 0.080 |
Why?
|
| Sex Factors | 6 | 2022 | 10633 | 0.080 |
Why?
|
| Hip | 1 | 2010 | 256 | 0.080 |
Why?
|
| Body Weight | 4 | 2017 | 4628 | 0.080 |
Why?
|
| Cholesterol, HDL | 4 | 2022 | 1820 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13594 | 0.080 |
Why?
|
| Estrogens | 1 | 2015 | 1536 | 0.080 |
Why?
|
| Cell Movement | 1 | 2020 | 5216 | 0.080 |
Why?
|
| Colombia | 1 | 2009 | 287 | 0.080 |
Why?
|
| Celiac Disease | 1 | 2016 | 820 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2460 | 0.080 |
Why?
|
| Young Adult | 13 | 2024 | 60131 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 794 | 0.070 |
Why?
|
| Amidohydrolases | 1 | 2009 | 160 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2014 | 1751 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2009 | 387 | 0.070 |
Why?
|
| Databases, Factual | 4 | 2018 | 8094 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2020 | 3205 | 0.070 |
Why?
|
| RNA-Binding Proteins | 5 | 2016 | 1891 | 0.070 |
Why?
|
| Sample Size | 3 | 2016 | 848 | 0.070 |
Why?
|
| Physicians, Family | 1 | 2009 | 349 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 677 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 864 | 0.070 |
Why?
|
| Follow-Up Studies | 9 | 2022 | 39394 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1135 | 0.070 |
Why?
|
| Sulfur Radioisotopes | 2 | 1996 | 113 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2016 | 4148 | 0.070 |
Why?
|
| Epigenomics | 2 | 2024 | 961 | 0.070 |
Why?
|
| Logistic Models | 4 | 2016 | 13318 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2905 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 1991 | 1207 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2008 | 395 | 0.070 |
Why?
|
| Principal Component Analysis | 2 | 2020 | 948 | 0.070 |
Why?
|
| Health Literacy | 1 | 2012 | 467 | 0.070 |
Why?
|
| Chest Pain | 1 | 2013 | 1101 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 640 | 0.060 |
Why?
|
| Mental Health | 1 | 2020 | 3275 | 0.060 |
Why?
|
| Fatigue | 1 | 2013 | 1557 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11230 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2893 | 0.060 |
Why?
|
| Osteoporosis | 2 | 2012 | 1606 | 0.060 |
Why?
|
| Age of Onset | 3 | 2023 | 3346 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 97 | 0.060 |
Why?
|
| Codon | 1 | 2006 | 599 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 1248 | 0.060 |
Why?
|
| Models, Biological | 2 | 2018 | 9499 | 0.060 |
Why?
|
| Aged, 80 and over | 10 | 2024 | 59739 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 4413 | 0.060 |
Why?
|
| Cells, Cultured | 5 | 2019 | 19023 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1194 | 0.060 |
Why?
|
| Coronary Disease | 2 | 2017 | 5919 | 0.060 |
Why?
|
| Chick Embryo | 2 | 1996 | 975 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2010 | 1531 | 0.060 |
Why?
|
| Glutamine | 1 | 2006 | 578 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 9213 | 0.050 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 23 | 0.050 |
Why?
|
| Hypertension | 2 | 2014 | 8617 | 0.050 |
Why?
|
| Calcium | 1 | 1996 | 5792 | 0.050 |
Why?
|
| Arginine | 1 | 2006 | 932 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7460 | 0.050 |
Why?
|
| Mice | 10 | 2019 | 82072 | 0.050 |
Why?
|
| tRNA Methyltransferases | 2 | 2016 | 50 | 0.050 |
Why?
|
| Child | 10 | 2024 | 80960 | 0.050 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2022 | 21 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2018 | 1197 | 0.050 |
Why?
|
| PubMed | 1 | 2023 | 130 | 0.050 |
Why?
|
| Registries | 2 | 2017 | 8384 | 0.050 |
Why?
|
| Glutamic Acid | 2 | 2008 | 1191 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2006 | 598 | 0.050 |
Why?
|
| Homozygote | 2 | 2022 | 1780 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2023 | 204 | 0.050 |
Why?
|
| Gene Expression | 4 | 2021 | 7603 | 0.050 |
Why?
|
| Radiography | 1 | 2013 | 6991 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 1705 | 0.050 |
Why?
|
| Quality of Life | 2 | 2020 | 13510 | 0.050 |
Why?
|
| Stroke | 2 | 2021 | 9756 | 0.050 |
Why?
|
| Biology | 1 | 2024 | 292 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 5801 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 1151 | 0.050 |
Why?
|
| Subcutaneous Fat | 2 | 2019 | 404 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2014 | 5151 | 0.050 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2021 | 57 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
| Fibrosis | 2 | 2022 | 2080 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 325 | 0.050 |
Why?
|
| Drosophila | 2 | 2019 | 1513 | 0.040 |
Why?
|
| Spain | 1 | 2022 | 485 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4939 | 0.040 |
Why?
|
| Comorbidity | 1 | 2015 | 10592 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2010 | 2421 | 0.040 |
Why?
|
| Mannose | 1 | 2020 | 122 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1836 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 1991 | 3713 | 0.040 |
Why?
|
| Diphosphonates | 1 | 2005 | 634 | 0.040 |
Why?
|
| Spermine Synthase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Indians, North American | 2 | 2013 | 354 | 0.040 |
Why?
|
| Receptors, Odorant | 1 | 2020 | 67 | 0.040 |
Why?
|
| Access to Information | 1 | 2023 | 317 | 0.040 |
Why?
|
| Introns | 2 | 2016 | 969 | 0.040 |
Why?
|
| Base Sequence | 2 | 2013 | 12430 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 386 | 0.040 |
Why?
|
| Hyperinsulinism | 2 | 2013 | 402 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 710 | 0.040 |
Why?
|
| Gout Suppressants | 1 | 2021 | 177 | 0.040 |
Why?
|
| Imidazoles | 1 | 2005 | 1169 | 0.040 |
Why?
|
| Financial Management | 1 | 2020 | 161 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 10400 | 0.040 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2019 | 144 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2019 | 263 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4790 | 0.040 |
Why?
|
| Sickle Cell Trait | 1 | 2019 | 86 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2021 | 994 | 0.040 |
Why?
|
| Boston | 3 | 2016 | 9377 | 0.040 |
Why?
|
| Societies, Medical | 2 | 2020 | 3968 | 0.040 |
Why?
|
| CpG Islands | 1 | 2022 | 1210 | 0.040 |
Why?
|
| Lipoprotein Lipase | 1 | 2018 | 133 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4124 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2020 | 344 | 0.040 |
Why?
|
| Taurine | 1 | 2018 | 92 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 229 | 0.040 |
Why?
|
| Body Fat Distribution | 1 | 2019 | 246 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8559 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14484 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 1101 | 0.040 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Physicians, Primary Care | 1 | 2024 | 625 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2021 | 42683 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 338 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2649 | 0.030 |
Why?
|
| Cell Size | 1 | 2019 | 626 | 0.030 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2023 | 1198 | 0.030 |
Why?
|
| Somatomedins | 1 | 2017 | 179 | 0.030 |
Why?
|
| Genetic Code | 1 | 1996 | 139 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2018 | 368 | 0.030 |
Why?
|
| Isomerism | 1 | 1996 | 198 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 160 | 0.030 |
Why?
|
| Xanthines | 1 | 2016 | 121 | 0.030 |
Why?
|
| Ribonucleosides | 1 | 2016 | 79 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 1996 | 69 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1996 | 283 | 0.030 |
Why?
|
| Linear Models | 2 | 2017 | 5891 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2017 | 361 | 0.030 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 289 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 1996 | 366 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2019 | 606 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1418 | 0.030 |
Why?
|
| China | 1 | 2022 | 2395 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2017 | 2858 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1996 | 862 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 239 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2017 | 419 | 0.030 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 2008 | 0.030 |
Why?
|
| Autoradiography | 1 | 1996 | 728 | 0.030 |
Why?
|
| Infant | 4 | 2021 | 36556 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 6214 | 0.030 |
Why?
|
| Health Surveys | 2 | 2016 | 4055 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2008 | 5033 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11521 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2108 | 0.030 |
Why?
|
| Cell Line | 3 | 2017 | 15604 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 271 | 0.030 |
Why?
|
| Colon | 1 | 2023 | 1803 | 0.030 |
Why?
|
| Interdisciplinary Studies | 1 | 2015 | 86 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1839 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2016 | 178 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1553 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 183 | 0.030 |
Why?
|
| Time Factors | 5 | 2022 | 40261 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 13427 | 0.030 |
Why?
|
| Uric Acid | 1 | 2021 | 806 | 0.030 |
Why?
|
| Glycine | 1 | 2018 | 672 | 0.030 |
Why?
|
| Chickens | 1 | 1996 | 845 | 0.030 |
Why?
|
| Binding Sites | 2 | 2015 | 6023 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2631 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15951 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2019 | 1140 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 590 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 22379 | 0.030 |
Why?
|
| Neoplasms | 3 | 2024 | 22389 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1731 | 0.030 |
Why?
|
| Sp3 Transcription Factor | 1 | 2013 | 30 | 0.030 |
Why?
|
| Methionine | 1 | 1996 | 573 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 611 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2018 | 1229 | 0.030 |
Why?
|
| Nutrition Surveys | 2 | 2011 | 1738 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 17629 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2023 | 2167 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2020 | 1024 | 0.030 |
Why?
|
| Intestines | 1 | 2023 | 1911 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 809 | 0.030 |
Why?
|
| Cholesterol Esters | 1 | 2013 | 72 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 586 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2017 | 834 | 0.030 |
Why?
|
| Thyroxine | 1 | 2017 | 665 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 81903 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 736 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1990 | 0.030 |
Why?
|
| Biological Clocks | 1 | 1995 | 321 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 654 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 859 | 0.030 |
Why?
|
| Family Health | 1 | 2017 | 1255 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 942 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2013 | 23653 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1608 | 0.030 |
Why?
|
| Parents | 1 | 2006 | 3597 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2023 | 6320 | 0.030 |
Why?
|
| Transaminases | 1 | 2013 | 199 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1714 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2023 | 2974 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2013 | 163 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 290 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2015 | 400 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1304 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 873 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2749 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2542 | 0.020 |
Why?
|
| Ireland | 1 | 2012 | 170 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 1995 | 1755 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 771 | 0.020 |
Why?
|
| Retinoblastoma | 1 | 1995 | 321 | 0.020 |
Why?
|
| Lysophospholipase | 1 | 2011 | 66 | 0.020 |
Why?
|
| Chromatin | 1 | 2024 | 2981 | 0.020 |
Why?
|
| Social Marketing | 1 | 2011 | 52 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2018 | 1505 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 422 | 0.020 |
Why?
|
| Cricetinae | 1 | 1995 | 2423 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 299 | 0.020 |
Why?
|
| Feedback | 1 | 1995 | 799 | 0.020 |
Why?
|
| Japan | 1 | 2016 | 1418 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 1991 | 152 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 657 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11116 | 0.020 |
Why?
|
| Syndrome | 1 | 2017 | 3274 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4168 | 0.020 |
Why?
|
| Camptothecin | 1 | 1995 | 600 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2018 | 3775 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3592 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2011 | 142 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 684 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2016 | 631 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 1614 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Hemeproteins | 1 | 2010 | 61 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1642 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2012 | 454 | 0.020 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2010 | 61 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 170 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 1091 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2017 | 1171 | 0.020 |
Why?
|
| Light | 1 | 1996 | 1355 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2013 | 627 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2011 | 171 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2020 | 8544 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 263 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 1447 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2017 | 1245 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 472 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3629 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 115 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1658 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4290 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 1369 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 997 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 378 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2017 | 2202 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 482 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5323 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2008 | 8317 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 2268 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 1970 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 642 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 1839 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1824 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3914 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2008 | 76 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 294 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 2660 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 810 | 0.020 |
Why?
|
| Metagenomics | 1 | 2012 | 474 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 30046 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1515 | 0.020 |
Why?
|
| Lod Score | 1 | 2008 | 600 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2017 | 3659 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2012 | 718 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 1133 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2008 | 110 | 0.020 |
Why?
|
| Patient Selection | 1 | 2020 | 4265 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2012 | 880 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 3076 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 1995 | 1862 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 776 | 0.020 |
Why?
|
| Professional Practice | 1 | 2009 | 314 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2024 | 4748 | 0.020 |
Why?
|
| Privacy | 1 | 2009 | 233 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 5404 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 2682 | 0.020 |
Why?
|
| Gestational Age | 1 | 2016 | 3621 | 0.020 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2008 | 167 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7058 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1885 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 746 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 515 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2012 | 1149 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1891 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2121 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2204 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 455 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 1222 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 26428 | 0.020 |
Why?
|
| Body Size | 1 | 2008 | 463 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2007 | 534 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2932 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 614 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2020 | 3463 | 0.010 |
Why?
|
| RNA Interference | 1 | 2013 | 2835 | 0.010 |
Why?
|
| Biopsy | 1 | 2016 | 6805 | 0.010 |
Why?
|
| Stem Cells | 1 | 2017 | 3539 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18435 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2437 | 0.010 |
Why?
|
| Brain | 1 | 1991 | 27453 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3433 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 1894 | 0.010 |
Why?
|
| International Cooperation | 1 | 2010 | 1436 | 0.010 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 625 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9264 | 0.010 |
Why?
|
| Reference Values | 1 | 2010 | 4940 | 0.010 |
Why?
|
| Exercise Test | 1 | 2011 | 2187 | 0.010 |
Why?
|
| Perception | 1 | 2009 | 1209 | 0.010 |
Why?
|
| Patients | 1 | 2009 | 908 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8513 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 3608 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3782 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5801 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4592 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4794 | 0.010 |
Why?
|
| Medicine | 1 | 2009 | 947 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8748 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2055 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5763 | 0.010 |
Why?
|
| Testosterone | 1 | 2011 | 2493 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12467 | 0.010 |
Why?
|
| Data Collection | 1 | 2009 | 3324 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 2228 | 0.010 |
Why?
|
| Health Promotion | 1 | 2011 | 2210 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3859 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2014 | 4544 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2010 | 3443 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 23786 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 4056 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 9344 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9384 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 2173 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1995 | 1647 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 6131 | 0.000 |
Why?
|